Kaizen Financial Strategies’s Gilead Sciences GILD Stock Holding History

Kaizen Financial Strategies’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$351K	Buy	2,784 +476	+21%	+$62.7K	0.11%	126
2026 Q1	$320K	Buy	2,308 +47	+2%	+$6.58K	0.14%	120
2025 Q4	$277K	Buy	2,261 +6	+0.3%	+$729	0.12%	134
2025 Q3	$278K	Sell	2,255 -188	-8%	-$21.4K	0.13%	123
2025 Q2	$271K	Buy	2,443 +223	+10%	+$23.7K	0.14%	121
2025 Q1	$249K	Sell	2,220 -187	-8%	-$19.3K	0.14%	117
2024 Q4	$222K	Buy	+2,407	New	+$217K	0.13%	117

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Kaizen Financial Strategies's GILD Position: Q2 2026 in Review

Kaizen Financial Strategies increased its Gilead Sciences (GILD) stake by 21% in Q2 2026, buying an estimated $62.7K and bringing the position to 2,784 shares worth $351K. The position accounts for 0.11% of the portfolio, ranked #126.

Kaizen Financial Strategies first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. 976 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Kaizen Financial Strategies held 2,784 shares of Gilead Sciences worth $351K as of Q2 2026.
Kaizen Financial Strategies bought 476 Gilead Sciences shares in Q2 2026, an estimated $62.7K.
Gilead Sciences made up 0.11% of Kaizen Financial Strategies's portfolio in Q2 2026, its #126 holding.
Kaizen Financial Strategies first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
976 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Kaizen Financial Strategies's 13F filing for Q2 2026, filed 30 Jul 2026.